Home > News > Liedekerke successfully assisted 3i portfolio company Havea in the acquisition of Ixx Pharma
Print pageprint Stay Informedprint

NEWS

Liedekerke successfully assisted 3i portfolio company Havea in the acquisition of Ixx Pharma

calendar_new
30/09/2021

Havea Group, one of the European leaders in natural health products, acquired ixX pharma, a key Belgian player in food supplements.

ixX Pharma, which has a strong presence in the Benelux, will be placed under the umbrella brand Aragan. With this acquisition, Havea Group is strengthening its position in Belgium where it already markets its Densmore and Vitavea brands. It will also build on its Aragan brand, which is mainly present in France and generates revenue of almost €30m.

Liedekerke’s team advising on all legal aspects of the transaction was led by Damien Conem, (Partner) and further consisted of Davy Vandenbussche (Senior Associate), Charline Cogels (Associate) and Charlotte Ferron (Associate).

Read the press coverage here.
For more information, don't hesitate to reach out to Jacques, Davy, Charline or Charlotte.